OMADA Health CFO and CEO Executing Rule‑Based 10(b)(5) Trades, CFO Craig Buys 405 Shares After 18.5% Rally, Signaling Insider Confidence in Stock’s Upward Trend.

Insider Activity Highlights a Strategic Shift

On June 30, 2026, Chief Accounting Officer Gracey Craig executed a 10(b)(5)‑planned purchase of 405 shares of OMADA Health at $22.00, adding 15 846 shares to her holding. A week earlier, Craig had sold 2 084 shares at $20.00, reducing her stake to 2 941 shares. The two trades are part of a larger pattern of disciplined, rule‑based activity that has seen her buy and sell roughly 6 000 shares in the past month. While the buy is modest compared to her total holding (over 35 000 shares), the timing—just after a 18.5 % weekly price rally—suggests confidence that the share price is poised to continue its upward trend.

What This Means for Investors

Craig’s 10(b)(5) plan is a common mechanism for insiders to lock in gains or spread out purchases in a compliant manner. The fact that she is buying while the market is on an upswing signals she believes the stock has reached a “fair” valuation. The simultaneous sale of 2 084 shares at $20.00 a day earlier may reflect a liquidity need or a strategic rebalancing of her portfolio. For shareholders, this is a reassuring sign that senior management’s market view aligns with the recent rally, yet it also reminds investors that insiders will continue to execute trades under their pre‑approved plans, potentially adding volatility if large blocks are sold in a short period.

Gracey Craig: A Profile of Consistent Insider Activity

Craig’s trading history over the last 12 months shows a steady cycle of purchases and sales that mirror the stock’s price swings. She bought 16 470 shares in early March, sold 2 083 shares in early June, and has since been alternating between buying around $18–$22 and selling near $20–$23. Her 10(b)(5) plan, adopted March 13, 2026, has been exercised on a regular schedule (late June, early July) and appears to be a key component of her personal investment strategy. Unlike some executives who use option exercises or large block sales, Craig’s activity is granular and rule‑compliant, suggesting she is more focused on portfolio management than on opportunistic trading.

Broader Insider Context

While Craig is the focal point of this article, other senior officers—Chief Financial Officer Steven Cook and CEO Sean Duffy—have also executed 10(b)(5) trades in late June and early July. Cook’s sale of 300 shares at $22 and a purchase of 300 shares at $8.28 illustrate a different risk appetite, possibly reflecting a long‑term view of the stock’s value. Duffy’s series of sales in June, totaling tens of thousands of shares, underscores a broader trend of insiders selling large blocks under their pre‑approved plans, potentially signaling a redistribution of capital rather than an adverse view of the company.

Investor Takeaway

The current round of insider trades, led by Craig’s timely purchase, indicates that senior management feels comfortable with OMADA Health’s recent performance and its growth trajectory in the virtual‑health space. However, the ongoing pattern of 10(b)(5) sales—especially by Cook and Duffy—serves as a reminder that large, rule‑based trades can inject volatility. Investors should monitor the company’s earnings guidance and market sentiment, noting that insider activity is a useful but not definitive barometer of future performance.